|
Real-time
Euronext Paris
07:12:59 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 76.87 EUR | -0.38% |
|
-0.52% | -7.06% |
| 09-02 | Owkin signs AI drug discovery deal with Boehringer for cancer, immunology | RE |
| 09-02 | Sanofi : Gets a Buy rating from Deutsche Bank | ZD |
| Market Cap | 92.44B 107B 87.08B 79.34B 148B 10,122B 149B 1,031B 400B 5,175B 402B 394B 17,001B | P/E 2026 * |
12.3x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 104B 120B 97.88B 89.18B 167B 11,377B 168B 1,159B 450B 5,817B 452B 442B 19,108B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 1.98x |
| Free-Float |
88.34% | Yield 2026 * |
5.51% | Yield 2027 * | 5.83% |
Last Transcript : Sanofi
| 1 day | -0.39% | ||
| 1 week | -0.54% | ||
| Current month | +0.07% | ||
| 1 month | +3.17% | ||
| 3 months | +4.54% | ||
| 6 months | -3.76% | ||
| Current year | -7.08% |
| 1 week | 76.43 |  | 78.15 |
| 1 month | 73.63 | | 79.36 |
| Current year | 71.25 | | 84.97 |
| 1 year | 71.25 | | 91.15 |
| 3 years | 71.25 | | 110.88 |
| 5 years | 71.25 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 | Buy | Executive/Senior Manager | 840 | 0.0001% | ||
| 8/20/26 | Buy | 1,422 | 0.0001% | |||
| 8/20/26 | Buy | Chief Technology Officer | 168 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.41% | -0.54% | -10.75% | -21.60% | 107B | |
| +0.01% | -2.47% | +57.79% | +108.23% | 1,034B | |
| +1.48% | +1.93% | +54.56% | +71.49% | 663B | |
| +0.67% | -0.45% | +23.50% | +76.60% | 462B | |
| +1.52% | -2.64% | +31.50% | +37.55% | 344B | |
| -0.26% | +5.26% | +27.28% | +47.37% | 307B | |
| +1.28% | -0.12% | -0.90% | +13.19% | 251B | |
| +1.08% | +0.57% | +54.34% | +72.51% | 239B | |
| +1.46% | +3.73% | -16.02% | -53.27% | 207B | |
| -0.21% | +1.03% | +32.74% | +95.19% | 186B | |
| Average | +0.41% | -0.77% | +25.40% | +44.73% | 380.05B | |
| Weighted average by Cap. | +0.43% | -0.86% | +36.95% | +65.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.68B 55.27B 44.92B 40.93B 76.5B 5,221B 77.07B 532B 206B 2,669B 208B 203B 8,769B | 50.81B 58.9B 47.86B 43.61B 81.51B 5,564B 82.12B 567B 220B 2,844B 221B 216B 9,344B |
| Net income | 7.91B 9.17B 7.45B 6.79B 12.69B 866B 12.79B 88.23B 34.24B 443B 34.43B 33.68B 1,455B | 9.24B 10.71B 8.71B 7.93B 14.83B 1,012B 14.94B 103B 40.01B 517B 40.24B 39.36B 1,700B |
| Net Debt | 11.46B 13.28B 10.79B 9.83B 18.38B 1,255B 18.52B 128B 49.59B 641B 49.87B 48.78B 2,107B | 8.3B 9.63B 7.82B 7.13B 13.32B 909B 13.42B 92.61B 35.94B 465B 36.14B 35.35B 1,527B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | €76.87 | -0.38% | 315,951 |
| 26-09-02 | €77.16 | +0.39% | 1,244,986 |
| 26-09-01 | €76.86 | +0.07% | 1,718,967 |
| 26-08-31 | €76.81 | -0.57% | 2,863,251 |
| 26-08-28 | €77.25 | -0.04% | 1,056,025 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
